Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Vinay Prasad
Fierce Biotech
CBER Director Vinay Prasad to depart FDA—again
Prasad has drawn increased criticism throughout his tenure, especially from the rare disease community.
Darren Incorvaia
Mar 6, 2026 5:30pm
Pfizer CEO Albert Bourla levels criticism of CBER's Vinay Prasad
Mar 3, 2026 4:58pm
Autoimmune CAR-T: Navigating the FDA’s new regulatory playbook
Feb 27, 2026 7:45am
Fierce Biotech
FDA to ‘carefully shepherd’ CAR-T for autoimmune disease: Prasad
Feb 3, 2026 11:40am
In COVID vax debate, administration leaders not aligned: Axios
Jan 30, 2026 1:21pm
Merck, Sanofi, AZ shots for RSV now under scrutiny by FDA
Dec 9, 2025 11:52am
